Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction

被引:0
|
作者
Jaimo Ahn
Maureen Murphy
Stephen Kratowicz
Alan Wang
Arnold J Levine
Donna L George
机构
[1] University of Pennsylvania School of Medicine,>Department of Genetics
[2] Fox Chase Cancer Center,Department of Pharmacology
[3] Princeton University,Department of Molecular Biology
[4] The Rockefeller University,undefined
来源
Oncogene | 1999年 / 18卷
关键词
p53; repression; stathmin; FKBP25;
D O I
暂无
中图分类号
学科分类号
摘要
The p53 tumor suppressor protein can function as an activator and a repressor of gene transcription. Currently, the mechanism of transcriptional repression by p53 is poorly understood. To aid in clarifying this mechanism, we carried out studies designed to identify specific target genes that are down-regulated following p53 induction. Among the negative p53-response genes revealed by our screening protocols are those encoding stathmin (Op18), a tubulin-associated protein implicated in cell signaling pathways, and an FK506/rapamycin-binding protein, FKBP25. Stathmin and FKBP25 exhibit decreased expression in both human and murine immortalized and transformed cell lines following induction of wild-type p53 by several stimuli that result in DNA damage. Candidate p53-repressed genes such as these provide the necessary markers to delineate the mechanism and biological consequences of transcriptional repression mediated by p53.
引用
收藏
页码:5954 / 5958
页数:4
相关论文
共 50 条
  • [1] Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction
    Ahn, J
    Murphy, M
    Kratowicz, S
    Wang, A
    Levine, AJ
    George, DL
    ONCOGENE, 1999, 18 (43) : 5954 - 5958
  • [2] Protumorigenic overexpression of Stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis
    Singer, Stephan
    Ehemann, Volker
    Brauckhoff, Antje
    Keith, Martina
    Vreden, Sebastian
    Schirmacher, Peter
    Breuhahn, Kai
    HEPATOLOGY, 2007, 46 (03) : 759 - 768
  • [3] Stathmin down-regulation can potentially restore mutant p53 function.
    Alli, E
    Yang, J
    Bash-Babula, J
    Hait, WN
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3689S - 3689S
  • [4] FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53
    Ochocka, Anna Maria
    Kampanis, Petros
    Nicol, Samantha
    Allende-Vega, Nerea
    Cox, Miranda
    Marcar, Lynnette
    Milne, Diane
    Fuller-Pace, Frances
    Meek, David
    FEBS LETTERS, 2009, 583 (04): : 621 - 626
  • [5] Redundant down-regulation pathways for p53
    Cinelli, M
    Magnelli, L
    Chiarugi, V
    PHARMACOLOGICAL RESEARCH, 1998, 37 (02) : 83 - 85
  • [6] Down-regulation of β-catenin by activated p53
    Sadot, E
    Geiger, B
    Oren, M
    Ben-Ze'ev, A
    MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (20) : 6768 - 6781
  • [7] p53-mediated negative regulation of stathmin/Op18 expression is associated with G2/M cell-cycle arrest
    Johnsen, JI
    Aurelio, ON
    Kwaja, Z
    Jörgensen, GE
    Pellegata, NS
    Plattner, R
    Stanbridge, EJ
    Cajot, JF
    INTERNATIONAL JOURNAL OF CANCER, 2000, 88 (05) : 685 - 691
  • [8] Abrogation of the transactivation activity of p53 by BCCIP down-regulation
    Meng, Xiangbing
    Yue, Jingyin
    Liu, Zhihe
    Shen, Zhiyuan
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (03) : 1570 - 1576
  • [9] Anticancer Effects of Huaier are Associated with Down-Regulation of P53
    Xu, Xiao
    Wei, Qiang
    Wang, Kai
    Ling, Qi
    Xie, Haiyang
    Zhou, Lin
    Zheng, Shusen
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (09) : 2251 - 2254
  • [10] Down-regulation of p53 by PAX5 in lung cancer
    So, PL
    Saliba, RS
    Ginsburg, D
    Gruss, P
    Oren, M
    Stuart, ET
    DEVELOPMENTAL BIOLOGY, 1997, 186 (02) : A138 - A138